Kidney health and drug processing: new study on MK-8527
NCT ID NCT06295796
First seen Feb 20, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study looked at how the drug MK-8527 is processed in people with moderate and severe kidney problems compared to healthy people. 18 adults took a single dose of the drug, and researchers measured drug levels in the blood over time. The goal was to understand how kidney impairment affects drug exposure, safety, and tolerability, without testing any specific treatment hypothesis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research by Design ( Site 0001)
Chicago, Illinois, 60643, United States
Conditions
Explore the condition pages connected to this study.